S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock
S&P 500   4,273.79
DOW   33,562.86
QQQ   354.90
Is Verizon’s 7% Yield Too Good To Pass Up?
The single greatest medical breakthrough of all time? (Ad)
Surging Over 100%: Small Cap Electric Boat Maker Makes Waves
The Most Upgraded Stocks In May Are Moving Higher 
The single greatest medical breakthrough of all time? (Ad)
Will Nvidia Be the Lifeline Intel Desperately Needs?
Here’s Why Disney’s MCU is Sinking in Quicksand
The single greatest medical breakthrough of all time? (Ad)
Buffett-Backed BYD Caught In The Chinese Government's Stimulus
Here’s What Driving the 125% YTD Gains for Upstart Holdings Stock

BellRing Brands (BRBR) Price Target & Analyst Ratings

$36.99
-0.91 (-2.40%)
(As of 06/5/2023 ET)
Compare
Today's Range
$36.80
$37.72
50-Day Range
$33.01
$37.90
52-Week Range
$20.20
$37.91
Volume
862,198 shs
Average Volume
951,651 shs
Market Capitalization
$4.91 billion
P/E Ratio
33.63
Dividend Yield
N/A
Price Target
$40.15

BellRing Brands Consensus Rating and Price Target (2023)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Analyst Rating

Buy
Based on 12 Analyst Ratings

Consensus Analyst Price Target

$40.15
8.54% Upside
High Prediction$47.00
Average Prediction$40.15
Low Prediction$31.00
TypeCurrent
6/6/22 to 6/6/23
1 Month Ago
5/7/22 to 5/7/23
3 Months Ago
3/8/22 to 3/8/23
1 Year Ago
6/6/21 to 6/6/22
Consensus Rating
Buy
Buy
Moderate Buy
Moderate Buy
Strong Buy
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
0 Strong Buy rating(s)
Buy
12 Buy rating(s)
12 Buy rating(s)
9 Buy rating(s)
6 Buy rating(s)
Hold
0 Hold rating(s)
0 Hold rating(s)
1 Hold rating(s)
2 Hold rating(s)
Sell
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
0 Sell rating(s)
Consensus Price Target$40.15$38.25$33.00$31.14
Predicted Upside8.54% Upside22.95% Upside21.21% Upside23.04% Upside
Get BellRing Brands Upgrade and Downgrade Alerts

Sign-up to receive the latest news and ratings for BRBR and its competitors with MarketBeat's FREE daily newsletter.


BRBR Analyst Ratings By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.
Skip Chart & View Analyst Rating History

BRBR Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.
Skip Chart and View Analyst Price Target HistorySkip Chart & View Price History Table

BellRing Brands Stock vs. The Competition

TypeBellRing BrandsMedical CompaniesS&P 500
Consensus Rating Score
3.00
2.66
2.48
Consensus RatingBuyBuyHold
Predicted Upside8.54% Upside1,271.28% Upside219.76% Upside
News Sentiment RatingPositive News
Positive News
Positive News

Historical Target Prices and Ratings

DateBrokerageAnalyst NameActionRatingPrice TargetUpside/Downside on Report DateDetails
5/11/2023Mizuho
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$38.00 ➝ $47.00+30.63%
5/11/2023Barclays
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$38.00 ➝ $41.00+13.95%
5/10/2023Stephens
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$39.00 ➝ $43.00+19.34%
5/10/2023Needham & Company LLC
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$40.00 ➝ $44.00+22.12%
5/9/2023Bank of America
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$35.00 ➝ $41.00+12.98%
4/28/2023Jefferies Financial Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost Target$38.00 ➝ $42.00+15.80%
4/26/2023William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
J. Andersen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Initiated CoverageOutperform
4/13/2023Stifel Nicolaus
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageBuy$39.00+15.45%
4/12/2023Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$34.00 ➝ $42.00+25.41%
4/11/2023Morgan Stanley
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetOverweight$32.00 ➝ $39.00+12.20%
3/23/2023Truist Financial
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 UpgradeHold ➝ Buy$25.00 ➝ $40.00+33.38%
2/8/2023The Goldman Sachs Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Boost TargetBuy$36.00 ➝ $42.00+40.33%
12/14/2022Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
 Initiated CoverageOutperform$31.00+23.41%
(Data available from 6/6/2018 forward. View 10+ years of historical ratings with our analyst ratings screener.)












BRBR Price Target - Frequently Asked Questions

What is BellRing Brands's consensus rating and price target?

According to the issued ratings of 12 analysts in the last year, the consensus rating for BellRing Brands stock is Buy based on the current 12 buy ratings for BRBR. The average twelve-month price prediction for BellRing Brands is $40.15 with a high price target of $47.00 and a low price target of $31.00. Learn more on BRBR's analyst rating history.

Do Wall Street analysts like BellRing Brands more than its competitors?

Analysts like BellRing Brands more than other Medical companies. The consensus rating score for BellRing Brands is 3.00 while the average consensus rating score for medical companies is 2.66. Learn more on how BRBR compares to other companies.

Is BellRing Brands being upgraded by Wall Street analysts?

Over the previous 90 days, BellRing Brands's stock had 1 upgrade by analysts.

Does BellRing Brands's stock price have much upside?

According to analysts, BellRing Brands's stock has a predicted upside of 25.41% based on their 12-month price targets.

What analysts cover BellRing Brands?

Stock Ratings Reports and Tools

This page (NYSE:BRBR) was last updated on 6/6/2023 by MarketBeat.com Staff

My Account -